Harald Esterbauer

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (18F-Fluoro-L-DOPA-, 68Ga-DOTA- and 18F-Fluoro-Deoxyglucose-Based PET/CT) and of 123I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-Up.

Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (18F-Fluoro-L-DOPA-, 68Ga-DOTA- and 18F-Fluoro-Deoxyglucose-Based PET/CT) and of 123I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-Up.

Journal: Cancers
Published: November 11, 2025

Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis.

Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis.

Journal: European journal of endocrinology
Published: August 04, 2025

Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients.

Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients.

Journal: European journal of endocrinology
Published: February 12, 2025

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

Journal: The Journal of clinical endocrinology and metabolism
Published: October 31, 2024

Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients.

Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients.

Journal: Frontiers in endocrinology
Published: April 17, 2024

Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Journal: Blood
Published: March 20, 2023

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Journal: Cancer discovery
Published: April 26, 2021

Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes.

Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes.

Journal: American journal of cancer research
Published: October 24, 2020

LMO3 reprograms visceral adipocyte metabolism during obesity.

LMO3 reprograms visceral adipocyte metabolism during obesity.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: August 27, 2020

Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis.

Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis.

Journal: Cell
Published: June 17, 2020

Beneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages.

Beneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages.

Journal: Diabetes
Published: June 05, 2020

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.

Journal: Blood
Published: April 02, 2020
Showing 1-12 of 50

Last Updated: 09/26/2026